Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EQT Corporation Common Stock (EQT) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

EQT Corporation Common StockTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

EQT Corporation Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? EQT Corporation Common Stock trades at $52.56 (market cap $34.05B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: EQT Corporation Common Stock is far larger — about 3.2× Vaxcyte Inc. Common Stock's market cap, and EQT Corporation Common Stock pays a 1.21% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 1 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

EQTPCVX
Market Cap
$34.05B$10.51B
Volume
4,662,5842,644,694
Sector
EnergyHealth
52-Week High
$67.93$73.82
52-Week Low
$48.56$40.32
Typical Hold Time
1 Days0 Days
Enterprise Value
$39.59B$9.14B
Dividend Yield
1.21%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EQT Corporation Common Stock

EQT trades at $54.43, up 2.27% today, with a bullish technical outlook and strong analyst consensus. The stock benefits from robust profitability, with a net income margin of 28.61% and a P/E ratio of 12.63. Recent news highlights a dividend increase and positive natural gas market tailwinds, while institutional buying activity supports sentiment. Earnings have mostly beaten expectations, with Q3 2026 results pending.

The outlook for EQT is positive, driven by operational efficiency, favorable natural gas demand, and a strong balance sheet. Risks include commodity price volatility and execution of growth plans. With a consensus price target of $70.33 implying significant upside, the stock presents a compelling opportunity for investors seeking exposure to the energy sector.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQT
100% Buy0% Sell
Avg holding period · 1 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About EQT Corporation Common Stock

EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.

Read more on EQT →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →